4.7 Letter

No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year

期刊

DIABETES CARE
卷 39, 期 12, 页码 E214-E215

出版社

AMER DIABETES ASSOC
DOI: 10.2337/dc16-1522

关键词

-

资金

  1. NCATS NIH HHS [UL1 TR001863] Funding Source: Medline
  2. NIDDK NIH HHS [P30 DK045735] Funding Source: Medline

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Multidisciplinary Sciences

Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation

Bruce A. Perkins, Jennifer L. Sherr, Chantal Mathieu

Summary: Despite innovations in insulin therapy, most type 1 diabetes patients still struggle to achieve sufficient glycemic control. The future may lie in combining pharmacological solutions with automated insulin delivery methods, utilizing machine learning and other technologies to enhance effectiveness.

SCIENCE (2021)

Article Endocrinology & Metabolism

Diabetes Technology Meeting 2020

Trisha Shang, Jennifer Y. Zhang, B. Wayne Bequette, Jennifer K. Raymond, Gerard Cote, Jennifer L. Sherr, Jessica Castle, John Pickup, Yarmela Pavlovic, Juan Espinoza, Laurel H. Messer, Tim Heise, Carlos E. Mendez, Sarah Kim, Barry H. Ginsberg, Umesh Masharani, Rodolfo J. Galindo, David C. Klonoff

Summary: The Diabetes Technology Society hosted its annual meeting from November 12 to 14, 2020, bringing together speakers to cover various perspectives on diabetes technology. Topics included AI, digital health, glucose monitoring, and novel insulins. Attendees also witnessed a live demonstration of the latest advancements.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)

Article Endocrinology & Metabolism

Pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use, room temperature, liquid stable glucagon administered via an autoinjector pen to youth with type 1 diabetes

Bruce Buckingham, Jennifer Sherr, Steven J. Prestrelski, Valentina Conoscenti

Summary: The study aims to assess the efficacy, pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use glucagon formulation in youth with type 1 diabetes. The results show that the formulation effectively reverses low blood glucose concentrations in youth with type 1 diabetes.

PEDIATRIC DIABETES (2022)

Editorial Material Endocrinology & Metabolism

Diabetes Technology Meeting 2021

Nicole Y. Xu, Kevin T. Nguyen, Ashley Y. DuBord, John Pickup, Jennifer L. Sherr, Hazhir Teymourian, Eda Cengiz, Barry H. Ginsberg, Claudio Cobelli, David Ahn, Riccardo Bellazzi, B. Wayne Bequette, Laura Gandrud Pickett, Linda Parks, Elias K. Spanakis, Umesh Masharani, Halis K. Akturk, John S. Melish, Sarah Kim, Gu Eon Kang, David C. Klonoff

Summary: The Diabetes Technology Society held its annual meeting from November 4th to 6th, 2021, bringing together experts to discuss advancements in diabetes technology. The meeting covered a wide range of topics, including glucose monitoring, telehealth, insulin delivery, and the use of technology in pregnancy. A live demonstration of a mobile app for monitoring diabetic foot wounds was also presented.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2022)

Article Endocrinology & Metabolism

Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial

Jennifer L. Sherr, Bruce W. Bode, Gregory P. Forlenza, Lori M. Laffel, Melissa J. Schoelwer, Bruce A. Buckingham, Amy B. Criego, Daniel J. DeSalvo, Sarah A. MacLeish, David W. Hansen, Trang T. Ly

Summary: This study evaluated the use of the Omnipod 5 Automated Insulin Delivery System in very young children with type 1 diabetes. The results showed that the system was safe to use and led to improved glycemic control and reduced hypoglycemia in the participants.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Jennifer L. Sherr, Lutz Heinemann, G. Alexander Fleming, Richard M. Bergenstal, Daniela Bruttomesso, Helene Hanaire, Reinhard W. Holl, John R. Petrie, Anne L. Peters, Mark Evans

Summary: A technological solution for diabetes management in people requiring intensive insulin therapy has been sought for decades. Recent advancements in continuous glucose monitoring have allowed for modulation of insulin delivery through insulin pumps based on sensor glucose data. Automated insulin delivery systems have been granted regulatory approval and adopted in clinical care. This consensus report from the joint Diabetes Technology Working Group provides a review of the current landscape of these systems, with a focus on safety, and offers recommended actions. The development of these systems has been a collaborative effort between the European Association for the Study of Diabetes and the American Diabetes Association.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Jennifer L. Sherr, Lutz Heinemann, G. Alexander Fleming, Richard M. Bergenstal, Daniela Bruttomesso, Helene Hanaire, Reinhard W. Holl, John R. Petrie, Anne L. Peters, Mark Evans

Summary: A technologically advanced solution for managing diabetes in patients requiring intensive insulin therapy has been sought for many years. Recent advancements in continuous glucose monitoring have led to the development of automated insulin delivery systems, which have begun to be integrated into clinical care. This consensus report provides an overview of the current landscape of these systems, with a focus on safety, and includes recommended actions for improvement.

DIABETOLOGIA (2023)

Editorial Material Biochemistry & Molecular Biology

When insulin isn't enough: targeting glucagon in type 1 diabetes

Michelle Van Name, Jennifer Sherr

Summary: A phase 2 study failed to achieve its primary endpoint, but the treatment demonstrated clinically relevant improvements in glycemic control, suggesting its potential use as an adjunct to insulin therapy.

NATURE MEDICINE (2022)

Editorial Material Medicine, General & Internal

Seeking Simpler Solutions with Diabetes Technology

Jennifer Sherr

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Endocrinology & Metabolism

CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study

Darrell M. Wilson, Susan L. Pietropaolo, Maria Acevedo-Calado, Shuai Huang, Destiny Anyaiwe, David Scheinker, Andrea K. Steck, Madhuri M. Vasudevan, Siripoom V. McKay, Jennifer L. Sherr, Kevan C. Herold, Jessica L. Dunne, Carla J. Greenbaum, Sandra M. Lord, Michael J. Haller, Desmond A. Schatz, Mark A. Atkinson, Patrick W. Nelson, Massimo Pietropaolo

Summary: Continuous glucose monitoring (CGM) metrics can provide additional insights into progression to clinical stage 3 type 1 diabetes, helping to identify individuals who are likely to rapidly progress to this stage.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

Jennifer L. Sherr, Melissa Schoelwer, Tiago Jeronimo Dos Santos, Leenatha Reddy, Torben Biester, Alfonso Galderisi, Jacobus Cornelius van Dyk, Marisa E. Hilliard, Cari Berget, Linda A. DiMeglio

PEDIATRIC DIABETES (2022)

Article Endocrinology & Metabolism

Diabetes Technology Meeting 2022

Jingtong Huang, Andrea M. Yeung, Ashley Y. DuBord, Howard Wolpert, Peter G. Jacobs, Wei-An Lee, Andjela Drincic, Elias K. Spanakis, Jennifer L. Sherr, Priya Prahalad, Alexander Fleming, Victoria C. Hsiao, Tejaswi Kompala, Rayhan A. Lal, Maya Fayfman, Barry H. Ginsberg, Rodolfo J. Galindo, Andreas Stuhr, J. Geoffrey Chase, Bijan Najafi, Umesh Masharani, Jane Jeffrie Seley, David C. Klonoff

Summary: Diabetes Technology Society held its annual Diabetes Technology Meeting from November 3 to November 5, 2022. The meeting covered various topics including glucose, insulin, and ketone measurement, virtual diabetes care, metrics for diabetes management and outcome prediction, integration of continuous glucose monitor data into electronic health records, etc.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2023)

Article Endocrinology & Metabolism

Impact of school-supervised ultra-long-acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study

Laura M. Nally, Jennifer L. Sherr, Eileen Tichy, Kate Weyman, Andrea Urban, Veronika Shabanova, Sarah McCollum, Amy Steffen, William V. Tamborlane, Michelle Van Name

Summary: This study examined the feasibility of daily school-supervised basal insulin injections and their effect on reducing the risk of morning ketosis in youth with type 1 diabetes. The results showed that supervised injections of both glargine and degludec could progressively lower the proportion of participants with elevated β-hydroxybutyrate levels. Engaging school-based caregivers in the management of youth with type 1 diabetes may decrease the risk of clinically significant ketosis.

DIABETIC MEDICINE (2023)

Review Endocrinology & Metabolism

Update on Measuring Ketones

Jingtong Huang, Andrea M. M. Yeung, Richard M. M. Bergenstal, Kristin Castorino, Eda Cengiz, Ketan Dhatariya, Isabella Niu, Jennifer L. L. Sherr, Guillermo E. E. Umpierrez, David C. C. Klonoff

Summary: Ketone bodies are produced by the liver and used in states of low carbohydrate availability. High ketone concentrations can be present in diabetic ketoacidosis. Beta-hydroxybutyrate is the main ketone in blood during DKA, while acetoacetate is the main ketone in urine as DKA resolves.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2023)

Review Endocrinology & Metabolism

A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective

Johan Jendle, Peter Adolfsson, Pratik Choudhary, Klemen Dovc, Alexander Fleming, David C. Klonoff, Julia K. Mader, Nick Oliver, Jennifer L. Sherr, Jan Soupal, Lutz Heinemann

Summary: Interoperability of medical devices and data used in diabetes therapy is crucial for seamless integration and sharing of data, while adhering to regulatory and legal frameworks.

DIABETOLOGIA (2023)

暂无数据